| ASSET | YEAR | % RETURN |
|---|---|---|
Bristol-Myers Squibb (BMY) | 2010 | 8.05% |
Bristol-Myers Squibb (BMY) | 2011 | 38.55% |
Bristol-Myers Squibb (BMY) | 2012 | -4.05% |
Bristol-Myers Squibb (BMY) | 2013 | 66.85% |
Bristol-Myers Squibb (BMY) | 2014 | 15.55% |
Bristol-Myers Squibb (BMY) | 2015 | 18.45% |
Bristol-Myers Squibb (BMY) | 2016 | -11.77% |
Bristol-Myers Squibb (BMY) | 2017 | 7.09% |
Bristol-Myers Squibb (BMY) | 2018 | -13.07% |
Bristol-Myers Squibb (BMY) | 2019 | 29.33% |
Bristol-Myers Squibb (BMY) | 2020 | 0.24% |
Bristol-Myers Squibb (BMY) | 2021 | 3.36% |
Bristol-Myers Squibb (BMY) | 2022 | 19.52% |
Bristol-Myers Squibb (BMY) | 2023 | -25.95% |
Bristol-Myers Squibb (BMY) | 2024 | 15.49% |
Bristol-Myers Squibb (BMY) | 2025 | -10.13% |
